ð ãªãžã¥ã©ã³ãã©ãã¯ãšã¯äžäœäœãªã®ã§ããããïŒãªãéåœã§ã¯å€ãã®äººããã®æœè¡ãåããŠããã®ã§ããããïŒ
ããInstagramã§ã#ãªãžã¥ã©ã³ãã©ãã¯ããŸãã¯ã#Rejuranããšæ€çŽ¢ããã°ãç»é¢ãã£ã±ãã«éåœã®å¥³æ§ãã¡ã®ããã€èãã®èªæ®ãåçã衚瀺ãããŸãããã®PDRN補å€ã¯éåœã®PharmaResearch瀟ãéçºãããã®ã§ãéåœã®ç®èç§ã§ã¯äœå¹Žãåããåºã䜿çšãããŠããŸãããå°æ¹Ÿã§ã¯ãŸã å€ãã®æ¹ã ãããã«ã€ããŠç¥ããªãããã§ããç§ãåããŠèãããšãã¯å šãæå³ãããããŸããã§ããââããã©ãã¯ããã¯ã¹ãïŒãã¢ã«ãã³é žæ³šå°ãšäœãéãã®ã§ããããïŒ
ãŸãçµè«ããèšããšããªãžã¥ã©ã³ãã©ãã¯ã¯ææã¡æ³šå°ã«ãã£ãŠçç®å±€ã«æ³šå ¥ãããPDRN修埩éã§ããããã€ãããã£ã«ã©ã€ãçšã®æ©æ¢°æã¡æ³šå°ãšã¯ç°ãªããŸãããã®äž»æåã§ããPNïŒããªããªãã·ãªããã¯ã¬ãªããïŒã¯ãµãŒã¢ã³ã®ç²Ÿå·£ããæœåºããããã®ã§ãç§ãã¡äººéã®DNAã®å¡©åºå¯Ÿé åãš98%ãã®é«ãé¡äŒŒæ§ãæã£ãŠãããããç®èã«ããåžåçãéåžžã«é«ããã¢ã¬ã«ã®ãŒåå¿ãã»ãšãã©èµ·ãããŸããã
äžè¬çãªãã¢ã«ãã³é žæ³šå ¥ãšã®æå€§ã®éãã¯ããã¢ã«ãã³é žæ³šå ¥ãäž»ã«æ°Žåè£çµŠãç®çãšããŠããã®ã«å¯Ÿãããªãžã¥ã©ã³ãã©ãã¯ã¯æå·ããç®èããªã¢ã®ä¿®åŸ©ãšã³ã©ãŒã²ã³ã®æ°çãä¿é²ããèè³ªãæ ¹æ¬ããæ¹åãããšããç¹ã§ããå€ãã®äººã ã¯ãæœè¡åŸã®èããå åŽããèŒãå§ããããšè¡šçŸããŠããã衚é¢çãªä¿æ¹¿å¹æãšã¯ç°ãªããšæããŠããŸãã

ð¬ ãªãžã¥ã©ã³ãã©ãã¯ããã¯ã€ãããã¯ã¹ãã¬ããããã¯ã¹ïŒäžäœã©ã®ãããªéããããã®ã§ããããïŒ
å€ãã®äººããªãºã©ã³ã®3ã€ã®è²ãåºå¥ã§ããªããããããã«æ¯èŒè¡šãçšæããŸããð
| æ¯èŒå¯Ÿè±¡ãããžã§ã¯ã | â« ãã©ãã¯ããã¯ã¹ããŒã©ãŒ | ⪠ãã¯ã€ãããã¯ã¹HB | ðŽ èµ€ãç®± |
|---|---|---|---|
| äž»èŠæå | PNïŒé«ååéïŒ | PNïŒæ¹è¯åïŒ | PDRNïŒäœååéïŒ |
| äž»ãªå¹æ | ãã§ã€ã¹ãªãããšã¢ã³ããšã€ãžã³ã° | ç®ã®åšãå°çš | åºæ¬ã±ã¢ïŒãããè·¡ã®ä¿®åŸ© |
| 泚å°ã«ããæœè¡æ¹æ³ | ææã¡æ³šå°ïŒå»åž«ã«ããæäœïŒ | ææã¡æ³šå° | æ©æ¢°æã¡æ³šå°ã§ãææã¡æ³šå°ã§ãã©ã¡ãã§ãæ§ããŸããã |
| 容é | 2CC/æ¬ | 1CC/æ¬ | 2CC/æ¬ |
| åèäŸ¡æ Œ | 925,000ã380,000 | 92äžåãã30äžå | 915,000åãã250,000å |
| å¹æã®æç¶ | 6ã¶æãã12ã¶æ | 3ã6ã¶æ | 3ã6ã¶æ |
ð¡ ã©ã®ããã«éžã¶ã¹ããïŒïŒå šèº«ã®èè³ªãæ¹åãããå Žåã¯ãã©ãã¯ããã¯ã¹ãéžã³ãŸããããç®åšãã®çްãããããã¯ãã«ã¯ãã¯ã€ãããã¯ã¹ãé©ããŠããŸããäºç®ãéãããŠããå Žåããããè·¡ã®ä¿®åŸ©ãæãå Žåã¯ã¬ããããã¯ã¹ãéžã¶ãšè¯ãã§ããããå»åž«ã®ã¢ããã€ã¹ã«ãã£ãŠã¯ããã©ãã¯ããã¯ã¹ãšãã¯ã€ãããã¯ã¹ãçµã¿åãããŠäœ¿çšããããšããå§ãããããããããŸããã
ð ç§ãã«ã³ãã ã®ABIJOUã§ãªãžã¥ã©ã³ãã©ãã¯ãåããå šãŠã®äœéš
ä»åã¯ã«ã³ãã ã®ABIJOUç®èç§ã§ææã¡æ³šå°ãåããŸããããã®ã¯ãªããã¯ãéžãã çç±ã¯ãé¢é·ãææã¡æ³šå°ã«éåžžã«ç²ŸéããŠãããNaverã®è©äŸ¡ã§ã¯å€ãã®å°æ¹Ÿã®æ£è ããããé«ãè©äŸ¡ãåããŠããããã§ãã
ð¬ äºçŽããåžæã®æ¹ã¯ãçŽæ¥WeChatã®s-sourireãŸã§
ãé£çµ¡ãã ããã
æœè¡ã1é±éåã«äŒãããšãããã«äºçŽæ¥æãäžåœèªãžã®ç¿»èš³ãæé
ããŠãããŸããããŸããäºåã«ããã¥ã©ã«ãªåçãéã£ããšãããé¢é·ãã1ccã®ãã©ãã¯ããã¯ã¹ãã§ã€ã¹ã ãã§ååã ããšã¢ããã€ã¹ããŠãããŸãããç¡çã«è¿œå æ²»çãå§ããªããã®ãããªã¯ãªããã¯ã¯æ¬åœã«å®å¿ã§ããŸãã
ð± WeChatã䜿ããªãå Žåã§ããBeautsGOãå©çšããŠãåé¡ãããŸããã
ãã®ãã©ã
ããã©ãŒã ã§ã¯ããªãžã¥ã©ã³ãã©ãã¯ãæäŸããŠããã¯ãªããã¯ãçŽæ¥äºçŽããããšãã§ããäŸ¡æ Œãéæã«è¡šç€ºãããŠãããå
šéçšãç¹äœåäžåœèªã§ãµããŒãããŠããããŸãã
ð©º çŽæ¥èšºå¯
é¢
é·ã¯ã¹ãã³ã¹ã³ãŒãã䜿ã£ãŠç§ã®é¡ãèŠãŠãå
šäœçãªèè³ªã¯æªããªãã軜床ã®ããªã¢æ©èœã®äœäžããããšèšããŸããïŒå£ç¯ã®å€ããç®ã«ææã«ãªãïŒãCCæ²»çãè¡ãã°ããã修埩ããã®ã«ã¡ããã©è¯ããšã®ããšã§ããããŸããããŒã¹ã®ã¹ãã³ããŒã·ã§ã³ã䜵çšãããšå¹æãããã«é«ãŸããšãã¢ããã€ã¹ããŠãããŸãããç§ã¯ãã®ææ¡ã«åæããæçµçãªæ²»çå
容ã¯CCæ²»ç2ccã«ã¹ãã³ããŒã·ã§ã³3ccã䜵çšããããšã«ãªããŸããã
â¡ æ²»çã®æµã
ãŸ
ã30åéã麻é
ã¯ãªãŒã ãå¡åžããŸããé»ãç®±ã䜿ã£ãŠææã¡æ³šå°ãè¡ããé¢é·ãéåžžã«çްãéïŒçŽ32GïŒã䜿ã£ãŠãé¡ã®åéšäœã«çŽ1cmã®ééããããŠæ³šå°ãæœããŸãããé ¬ããã§ãïŒé¡ãããã«æ³šå°ãè¡ãã錻ã®åšãã¯é¿ããŸãããæ³šå°ãããã³ã«å°ãåºããããªçã¿ãšè»œãè
«ãããããŸããããæ³åããŠããããããã£ãšèããããçšåºŠã§ãçã¿ã¯4ã5段éäžã®4çšåºŠã§ãããææã¡æ³šå°å
šäœã«ãããæéã¯çŽ15åã§ãããã®åŸãæ°Žå
泚å°ãæ©æ¢°æã¡æ³šå°ã§è¡ããããã«çŽ10åããããŸããã
ð§Ž è¡åŸ
é¡ã«å°
ããªè
«ããã§ããŠããŸãããïŒããã¯ææã¡æ³šå°ã®æ£åžžãªçŸè±¡ã§ãïŒãçè·åž«ã20åéå·åŽããã¯ãšé®é广ã®ãããã§ã€ã¹ãã¹ã¯ãããŠãããŸãããåž°å®
ããé ã«ã¯è
«ãã¯ã»ãšãã©åŒããŠããŸããããé¡ã¯æ¥çŒãããããã«å°ãèµ€ããªã£ãŠããŸãããçè·åž«ããã¯ã24æéã¯æ°Žã«è§Šãããåç²§ããããæ±ãããããããªãããã«ãšæç€ºãããŸããããç¿æ¥ã«ã¯æ®éã«æŽé¡ãåç²§ãããŠãåé¡ãªãããã§ãã

â° ãªãžã¥ã©ã³ãã©ãã¯ã¯ã©ã®ãããã®ééã§æœè¡ãåããã°ããã®ã§ããïŒæã广çãªæ²»çããã°ã©ã ã¯ã©ã®ããã«çµãã¹ãã§ããããïŒ
ããã¯çãæãããå°ãã質åã§ãããªãžã¥ã©ã³ãã©ãã¯ã¯ããã¢ã«ãã³é žæ³šå°ã®ããã«æ¯æè¡ãããšã¯ã§ããŸãããããã«ã¯ç¬èªã®ããŒã¹ããããŸãã
ð ååæ²»çïŒéäžæïŒïŒé£ç¶ããŠ3åè¡ããååã®ééã¯2ã4é±éã§ãããã®æ®µéã§ã¯èã®èªå·±ä¿®åŸ©èœåãç¯ãããã®ãã®ã§ã广ã¯åãéããããšã«åŸã ã«é¡èã«ãªã£ãŠãããŸããå€ãã®äººã¯ååã®æ²»çã§ã¯ããŸãå€åãæããããªããããããŸãããã3åç®ã«ãªããšãèãæ¬åœã«éãããšå®æããã§ãããã
ð ä¿ææéïŒååæ²»ççµäºåŸã6ã12ã¶æããšã«1åè¿œå æ²»çãåããããšã§å¹æãç¶æã§ããŸããå ·äœçãªééã¯å人ã®çæŽ»ç¿æ £ã«ãã£ãŠç°ãªããŸãã倿Žãããé »ç¹ã«ããããå«ç ãããããæ¥å ã«é床ã«åœãã£ãããã人ã®å Žåãééã¯çããªãåŸåããããŸãã
â ïž ãæ³šæãã ããïŒ2åã®æ²»çã®éã«ã¯å°ãªããšã2é±éã®ééã空ããŠãã ãããããããããšã§ãPDRNãç®èã®äžã§ååã«ä¿®åŸ©äœçšãçºæ®ããããšãã§ããŸããæ²»çãããŸãã«ãé »ç¹ã«è¡ã£ãŠã广ã¯åäžããŸããããããç¡é§ãªãéã®æ¯åºã«ãªãã ãã§ãã
ð« ãªãžã¥ã©ã³ãã©ãã¯ã®çŠå¿äºé ãšãªã¹ã¯
ãªãžã¥ã©ã³ãã©ãã¯ã¯éåžžã«å®å šæ§ãé«ãã§ããïŒPDRNã¯äººäœã®DNAãš98%ã®é¡äŒŒæ§ãæã£ãŠããŸãïŒã以äžã®ãããªå Žåã«ã¯äœ¿çšããå§ãããŸããã
â åŠåš äžããã³æä¹³äžïŒæç¢ºãªç ç©¶ã«ãã£ãп害ã§ãããšèšŒæãããŠã¯ããŸããããå®å šãèæ ®ããŠæšå¥šãããŸããã
â æŽ»åæ§ã®ããããé床ã®ççãããå ŽåïŒæ³šå°ãè¡ããšææãæªåããå¯èœæ§ãããããããŸãããããæ²»ããŠããè¡ãããšããå§ãããŸãã
â èªå·±å ç«æ§çŸæ£ïŒPDRNã¯å ç«ä¿®åŸ©åå¿ãåŒãèµ·ãããããèªå·±å ç«æ§çŸæ£ã®æ£è ã«ãããŠã¯äžè¯åå¿ãçããå¯èœæ§ããããŸãã
â éã®ã¿ã³ãã¯è³ªã«ã¢ã¬ã«ã®ãŒãããå ŽåïŒPDRNã¯ãµãŒã¢ã³ããæœåºãããŠãããããããå°æ°ã§ãããéã®ã¿ã³ãã¯è³ªã«ã¢ã¬ã«ã®ãŒãããæ¹ã«ã¯é©ããŠããªãå¯èœæ§ããããŸãã
â ïž äžè¬çãªå¯äœçšïŒæ³šå°éšäœã®è»œãè «ãïŒ1ïœ2æ¥ã§åŒãïŒãããããªèµ€ã¿ïŒæ°æéã§æ¶ããïŒã軜床ã®çè¡ïŒå人差ããããŸãããå·åŽããã¯ã䜿çšãããšçç¶ãåãããŸãïŒãé節ãªå¯äœçšã¯éåžžã«ãŸãã§ãã
ð¡ è¿œå æ å ±ïŒé»ç®±æ²»çãåããåŸã2æ¥ç®ã«ç®èãç¹ã«ä¹Ÿç¥ãããšæãã人ãããŸãããããã¯æ£åžžãªçŸè±¡ã§ãããªããªããPDRNãçç®å±€ã§ä¿®åŸ©åå¿ãåŒãèµ·ããéã«ã¯äžå®éã®æ°Žåãæ¶è²»ãããããã§ãããã®ãããªæã«ã¯ã倧éã®ãã§ã€ã¹ãã¹ã¯ã䜿ãã®ã§ã¯ãªããå¯å°æ§ã®é«ã修埩ã¯ãªãŒã ã䜿çšããŠæ°Žåãéã蟌ããããšã倧åã§ããå人çã«ã¯ãCell Fusion C修埩ã¯ãªãŒã ãšIlliyoonç¥çµã¢ããé žä¿æ¹¿ã¯ãªãŒã ãäºéã«å¡ããšå¹æãéåžžã«è¯ãã§ããéåœã®ç®èç§å»ããé»ç®±æ²»çåŸ1é±éã¯æ¯æ¥2ãªããã«ã®æ°Žã飲ãããšãæšå¥šããŠãããããã«ãã£ãŠå åŽããæ°Žåãè£çµŠããããšãã§ããããè¯ã广ãåŸããããšãããŠããŸãã
â ãªãžã¥ã©ã³ãã©ãã¯ã«é¢ãããããã質åãšãã®çã
QïŒãªãžã¥ã©ã³ãã©ãã¯ãšJuvelookãã©ã¡ããè¯ãã§ããïŒ
AïŒäž¡è
ã¯
å
šãç°ãªã補åã§ãããªãžã¥ã©ã³ãã©ãã¯ã¯ä¿®åŸ©åã§ïŒPNã«ãã£ãŠã³ã©ãŒã²ã³ã®åçãä¿é²ããŸãïŒãJuvelookã¯å
å¡«åã§ïŒPCLã³ã©ãŒã²ã³ã䜿çšããŠå
å¡«ããŸãïŒãèè³ªãæ¹åãããå Žåã¯ãªãžã¥ã©ã³ãã©ãã¯ããç®ã®äžã®ããŒã¿ãå¹ã¿ãæ¹åãããå Žåã¯Juvelookãéžã¶ãšè¯ãã§ããããå€ãã®äººãäž¡æ¹ã䜵çšããŠããŸãããŸããªãžã¥ã©ã³ãã©ãã¯ã§è質ã修埩ãããã®åŸJuvelookã§å±éšçã«å
å¡«ããããšã§ã广ã¯1+1ïŒ2ã«ãªããŸãã
QïŒæœè¡åŸããã€é ãã广ãçŸããŸããïŒ
AïŒæœè¡çŽåŸã«ã¯ç®èããæ°Žåããã£ã·ãåžåããããããªæãã«ãªããŸãïŒæ°Žåãæµžéããããã§ããïŒãå®éã®PNä¿®åŸ©å¹æãé¡èã«ãªãã®ã¯2ïœ4é±éåŸã§ããååæ²»çã§ã¯3åã®æœè¡ãåããåŸãæã广çã§ããå€ãã®éåœã®ç®èç§ã§ã¯ãé»ç®±çæ³ãçµãã1ã¶æåŸã«å蚺ãåããããšãæšå¥šããŠãããå»åž«ã¯ååŸ©ç¶æ³ã確èªããäžã§ã次åã®æ²»çèšç»ã調æŽãããã©ãããæ±ºå®ããŸãã
QïŒèªåã§ãªãžã¥ã©ã³ãã©ãã¯ã賌å
¥ããŠææã¡æ³šå°ãè¡
ã£ãŠãããã§ããïŒ
AïŒçµ¶å¯Ÿã«ãã¡ã§ãïŒãªãžã¥ã©ã³ãã©ãã¯ã¯è³æ Œãæã€å»åž«ã®ã¿ã䜿çšããŠãããã®ã§ããææã¡æ³šå°ã®æ·±ããè§åºŠãååžãªã©ã¯å°éçãªå€æãå¿
èŠã§ããåžå Žã«ã¯åœç©ãå€ãåºåã£ãŠãããããé¡ã«æå·ãäžããå Žåããã®æå€±ã¯èšãç¥ããŸããã
QïŒéåœçã®Enhanceãšã¯ã©ã®ãããªéãããããŸããïŒ
AïŒå®éã«ã¯ã©ã¡ããPharmaResearchã補é ããŠãã補åã§ãããå°åã«ãã£ãŠããã±ãŒãžã³ã°ãåç§°ãç°ãªã£ãŠããŸããéåœã§ã¯RejuranãšåŒã°ããå°æ¹Ÿãæ±åã¢ãžã¢ã§ã¯EnhanceãšåŒã°ããŠããŸããæåã广ã¯åãã§ã販売åã ããç°ãªã£ãŠããã®ã§ãã
â ïž å 責äºé ïŒæ¬æã¯å人ã®äœéšãå ±æãããã®ã§ãããå»çäžã®ã¢ããã€ã¹ãæ§æãããã®ã§ã¯ãããŸãããå»ççŸå®¹æœè¡ã®å¹æã¯äººããããã§ãããå°éå»ã®èšºå¯ãšè©äŸ¡ãåºã«ã倿ãã ãããäŸ¡æ Œæ å ±ã¯åèçšã®ãã®ã§ãããå®éã®æœè¡é¢ã®æç€ºäŸ¡æ Œãã確èªãã ããã



